Nilai Buku saben Saham: Adlai Nortye Ltd (ANL)

Logo grafis Adlai Nortye Limited (ANL)

Optimized hub-based supply logistics ensure the stability of Adlai Nortye Ltd. (ANL), and this chart on the GURU.Markets terminal displays book value per share data, where the indicator value is 3.36. However, geopolitical discord between China and the West creates sales risks. Furthermore, stringent FDA requirements and the high cost of molecular oncology developments necessitate colossal capital for survival.

ANL (Adlai Nortye Ltd.) riwayat Nilai Buku saben Saham saka 21.02.2024 nganti 29.10.2026
Barang unggulan Adlai Nortye Ltd

For Adlai Nortye Ltd. (ANL), the net asset value per share reflects the real value of capital deployed in costly oncology research and expansion into the US and Chinese markets. This metric is calculated as the difference between the company's total assets and liabilities divided by the number of shares, allowing investors to verify the market price against the actual value of assets to avoid overpaying during a trend reversal.

Analisis pesaing

ONC - Aset Bersih saben Siji Saham|HALO - Aset Bersih saben Siji Saham|RVMD (Revolution Medicines) - Nilai Buku saben Saham|ascentage.com (AAPG) - Nilai Akuntansi saben Saham|CGON (CG Oncology) - Nilai Buku saben Saham|Nilai Buku saben Saham URGN|Aset Bersih saben Siji Saham Bicara Bio BCAX|Ekuitas saben Saham Personalis Genomics (PSNL)|Erasca, Inc. - Nilai Buku saben Saham|Nilai Akuntansi saben Saham delcath.com DCTH|YMAB (Y-mAbs Therapeutics, Inc.) - Nilai Buku saben Saham|AURA: Nilai Aset Bersih saben Saham|Aset Bersih saben Siji Saham candeltx.com CADL|Nilai Akuntansi Saham Accuray, Inc.|SLS - Nilai Akuntansi saben Saham|Nilai Akuntansi Saham actuatetherapeutics.com|Nilai Buku saben Saham CTOR (Citius Oncology)|Nilai Akuntansi saben Saham tuhurabio.com HURA|Nilai Akuntansi saben Saham TARA (Protara)|Fate Pharma - Nilai Buku saben Saham|Aset Bersih saben Siji Saham Aadi Bio (WHWK)|TCRX - Nilai Akuntansi Saham|Nilai Buku saben Saham CSBR|XBiotech (XBIT) - Nilai Aset Bersih saben Saham|CVM (CEL-SCI Corp.) - Nilai Buku saben Saham|Nilai Buku saben Saham OS Therapies, Inc.|Nilai Buku saben Saham Radiopharm Theranostics Limited RADX|Ekuitas saben Saham ARTV (artivabio.com)|Aset Bersih saben Siji Saham Veru VERU|Aset Bersih saben Siji Saham Tempest Therapeutics Inc TPST|Xilio - Nilai Buku saben Saham|RENB - Nilai Buku saben Saham|muraloncology.com - Nilai Buku saben Saham|Aset Bersih saben Saham Kairos Pharma|OKUR - Nilai Akuntansi saben Saham|Nilai Akuntansi Saham GDTC|Aset Bersih saben Siji Saham Curis, Inc. CRIS|Ekuitas saben Saham APLM (apollomicsinc.com)|THAR: Aset Bersih saben Siji Saham|Advanced Biomed Inc. - Nilai Aset Bersih saben Saham|Aset Bersih saben Siji Saham Genprex (GNPX)|Calidi Biotherapeutics (CLDI) - Nilai Akuntansi Saham|SBFM - Nilai Akuntansi saben Saham|Rega Buku Saham Xenetic Biosciences, Inc.|Nilai Akuntansi saben Saham SLRX (Salarius Pharmaceuticals)|Nilai Aset Bersih saben Saham purple-biotech.com|American Oncology Network - Nilai Buku saben Saham|Nilai Aset Bersih saben Saham BeiGene Ltd. BGNE|Nilai Akuntansi saben Saham Checkpoint Therapeutics, Inc|elevationoncology.com - Nilai Akuntansi Saham|ICAD - Aset Bersih saben Siji Saham|Ikena Oncology, Inc. (IKNA) - Aset Bersih saben Siji Saham|NTBL - Nilai Akuntansi saben Saham|Viracta Therapeutics, Inc. (VIRX) - Rega Buku Saham|Nilai Buku saben Saham MorphoSys Corp (MOR)|Ekuitas saben Saham NAYA Biosciences Corp (NAYA)|AAPGV (Ascentage Pharma Group) - Nilai Akuntansi saben Saham